Literature DB >> 23895770

Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.

A Kandulski1, D Jechorek, C Caro, J Weigt, T Wex, K Mönkemüller, P Malfertheiner.   

Abstract

BACKGROUND: Proton pump inhibitor (PPI)-refractory heartburn may be due to persistent gastro-oesophageal reflux, oesophageal hypersensitivity or functional heartburn (FH). The differentiation between non-erosive reflux disease (NERD) and FH may be very difficult. However, this differentiation is important for appropriate therapeutic management. Dilated intercellular spaces (DIS), papillary elongation (PE) and basal cell hyperplasia (BCH) can be all assessed by light microscopy. Whether these mucosal abnormalities allow the differentiation of NERD from FH in PPI-refractory patients is uncertain. AIM: To assess histopathological findings by light microscopy in patients with refractory heartburn to differentiate NERD from FH.
METHODS: Sixty-two patients with PPI-refractory symptoms underwent EGD and MII-pH after pausing PPI medication for 2 weeks before investigation. Twenty-five subjects without upper gastrointestinal symptoms were included as controls. Symptom assessment was based on the reflux disease questionnaire (RDQ). Biopsies were taken 3-5 cm above the gastro-oesophageal junction. DIS, PE, BCH and infiltration of immune cells were evaluated and a sum score was calculated.
RESULTS: Based on endoscopy and MII-pH, GERD was diagnosed in 43 patients (NERD: 20; ERD: 23) and FH in 19 patients. There was no difference in symptoms between the groups. Each individual histopathological item was different between the groups (P < 0.0001). Between NERD and FH, the most significant difference was found for DIS and the histopathological sum score (P < 0.001).
CONCLUSIONS: These findings suggest that oesophageal biopsies are useful to differentiate NERD from FH. Increased DIS and a histological sum score are the most significant histopathological abnormalities in NERD as compared with FH.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23895770     DOI: 10.1111/apt.12428

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  22 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

2.  The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.

Authors:  Lisa B Mahoney; Samuel Nurko; Rachel Rosen
Journal:  J Pediatr       Date:  2017-07-12       Impact factor: 4.406

Review 3.  Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone?

Authors:  Christos Triantos; Nikolaos Koukias; Georgios Karamanolis; Konstantinos Thomopoulos
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  Why differences between New York and New Delhi matter in approach to gastroesophageal reflux disease.

Authors:  Benjamin D Rogers; C Prakash Gyawali
Journal:  Indian J Gastroenterol       Date:  2019-10

Review 5.  Biomarkers of Reflux Disease.

Authors:  Leila Kia; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

6.  Update on Functional Heartburn.

Authors:  Takahisa Yamasaki; Jessica O'Neil; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

Review 7.  Gastrointestinal mucosal barrier function and diseases.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2016-04-05       Impact factor: 7.527

8.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

Review 9.  Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test?

Authors:  Arne Kandulski; Lukas Moleda; Martina Müller-Schilling
Journal:  Visc Med       Date:  2018-04-20

Review 10.  Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium.

Authors:  C Prakash Gyawali; Daniel Sifrim; Dustin A Carlson; Mary Hawn; David A Katzka; John E Pandolfino; Roberto Penagini; Sabine Roman; Edoardo Savarino; Roger Tatum; Michel Vaezi; John O Clarke; George Triadafilopoulos
Journal:  Neurogastroenterol Motil       Date:  2019-04-11       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.